Gene · 6612
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SEPT5 confers radioresistance by suppressing GSDME-dependent pyroptosis and antitumor immunity in non-small cell lung cancer. | Int Immunopharmacol | 2026 | 42743876 | PubTator, text mining | PubMed |
| SUMO3/RUNX1/AIRE/RCAN1 and DNMT3L/DYRK1A/Let-7c-5p/VEGF axes: immune dysregulation and genetic susceptibility as pulmonary risk factors in Down syndrome. | 3 Biotech | 2026 | 42245386 | PubTator, text mining | PubMed |
| Denaturing SUMO Immunoprecipitation From Mitotic Cells. | Bio Protoc | 2026 | 41971162 | PubTator, text mining | PubMed |
| Small Ubiquitin-Like Modifier 3 Attenuates Lung Ischemia-Reperfusion Injury Progression by Inhibiting Endoplasmic Reticulum Stress through Heat Shock Protein 70. | Am J Pathol | 2026 | 41881306 | PubTator, text mining | PubMed |
| Inhibition of coronaviral exoribonuclease activity by TRIM-mediated SUMOylation. | Proc Natl Acad Sci U S A | 2026 | 41871251 | PubTator, text mining | PubMed |
| Cellular strategies for repairing trapped protein-DNA complexes. | Front Pharmacol | 2026 | 41743125 | PubTator, text mining | PubMed |
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| SUMOylation machinery protein, PIAS4 role in breast cancer cell proliferation and drug sensitivity. | Mol Biol Rep | 2026 | 41615552 | PubTator, text mining | PubMed |
| A single-cell derived spheroid approach to dissect intratumoural heterogeneity in colorectal cancer: cell lines show changes in proteomes and therapeutic response to 5-FU. | J Cancer Res Clin Oncol | 2026 | 41580526 | PubTator, text mining | PubMed |
| Down-regulation of EHMT2 through irisin-mediated epigenetic modification promotes osteogenesis via promoting DLX3 transcription. | Cell Commun Signal | 2026 | 41555399 | PubTator, text mining | PubMed |
| SENP3 Promotes Hepatocyte Steatosis via De-SUMOylation of SREBP2. | Cell Biochem Funct | 2025 | 41254938 | PubTator, text mining | PubMed |
| A short SUMOylation tag modulates transcription factor activity. | J Biol Chem | 2025 | 41072767 | PubTator, text mining | PubMed |
| An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21. | Nat Commun | 2025 | 40993118 | PubTator, text mining | PubMed |
| Cooperation between ZEB2 and SP1 upregulates PD‑L1 and CCL2 to promote the immunosuppressive activity of tumor cells. | Int J Oncol | 2025 | 40970322 | PubTator, text mining | PubMed |
| A Vivo-Morpholino-Based Approach to Block Paralog-Specific SUMOylation. | Methods Mol Biol | 2025 | 40875124 | PubTator, text mining | PubMed |
| Identification of SUMOylation modifiers involved in lung adenocarcinoma progression and Osimertinib resistance by integrated bioinformatics analysis. | Sci Rep | 2025 | 40851084 | PubTator, text mining | PubMed |
| HDAC6-dependent deacetylation of SAE2 enhances SUMO1 conjugation for mitotic integrity. | EMBO J | 2025 | 40836035 | PubTator, text mining | PubMed |
| Screening, identification, and experimental validation of SUMOylation biomarkers in Parkinson's disease. | Hereditas | 2025 | 40781725 | PubTator, text mining | PubMed |
| Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy. | Front Immunol | 2025 | 40375990 | PubTator, text mining | PubMed |
| Interaction networks of SIM-binding groove mutants reveal alternate modes of SUMO binding and profound impact on SUMO conjugation. | Sci Adv | 2025 | 40367183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6612/papers